{"id":"NCT01020838","sponsor":"Life Molecular Imaging SA","briefTitle":"Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology","officialTitle":"An Open-label, Non-randomized Study to Evaluate the Efficacy and Safety of BAY94-9172 (ZK 6013443) Positron Emission Tomography (PET) Imaging for Detection/Exclusion of Cerebral Beta-amyloid When Compared to Postmortem Histopathology","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11","primaryCompletion":"2011-09","completion":"2013-12","firstPosted":"2009-11-26","resultsPosted":"2015-03-25","lastUpdate":"2016-05-27"},"enrollment":218,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Alzheimer Disease"],"interventions":[{"type":"DRUG","name":"Florbetaben (BAY94-9172)","otherNames":[]}],"arms":[{"label":"Florbetaben (BAY94-9172)","type":"EXPERIMENTAL"}],"summary":"To determine the sensitivity and specificity of the visual assessment of tracer uptake in the Florbetaben PET images compared to histological verification of the presence or absence of cerebral β-amyloid in the respective histopathologic post mortem specimens as the standard of truth","primaryOutcome":{"measure":"Sensitivity and Specificity of the Majority Read of Visual Assessment of Tracer Uptake Compared to Histological Verification of the Presence or Absence of Cerebral Beta-amyloid in Postmortem Specimens","timeFrame":"90-110 minutes post injection (PET image acquisition)","effectByArm":[{"arm":"Sensitivity (Interim Analysis Set)","deltaMin":77.36,"sd":null},{"arm":"Specificity (Interim Analysis Set)","deltaMin":94.2,"sd":null}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG001","p":null}]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":4},"locations":{"siteCount":19,"countries":["United States","Australia","France","Germany","Japan"]},"refs":{"pmids":["26823561","25824567"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":216},"commonTop":["Haematoma","Puncture site reaction","Injection site hematoma","Pyrexia","Erythema"]}}